The Journal of Antibiotics · 1972 · 170 citations · 19 references
MedicineOncologyPharmacologyCancer PharmacologyCarcinogenesisMedical OncologyOncology PharmacologyPharmacodynamics Of Anticancer AgentsPharmacodynamics Of Anticancer DrugsPharmacokinetics Of Anticancer DrugsSquamous Cell CarcinomaAnticancer Activity
Distribution of 3H-bleomycin among organs of normal mice of various ages and old mice bearing skin carcinoma or sarcoma induced by 20-methylcholanthrene was studied and the ratios of the antibacterial activity to the radioactivity were examined. Higher concentration was shown in carcinoma than in sarcoma and in the former more than 50% of 3H-bleomycin remained in an active form exhibiting antibacterial activity. Slight or no activity was observed in sarcoma. The selective effect of bleomycin on mouse skin carcinoma induced by 20-methylcholanthrene was thus suggested to be due to the low ability of the tumor to inactivate bleomycin and probably also to the high uptake in this tumor. Differences were also observed among distributions of 3H-bleomycin in lung and skin of mice of different ages. The higher concentration of its active form was shown in lung and skin of old mice at higher rate than in those of young ones. An enzyme that releases one mole of ammonia from bleomycin and which inactivates bleomycin was extracted from tissues. The bleomycin inactivating activity of the enzyme protein was significantly lower in the protein extracted from squamous cell carcinoma of mice skin induced by 20-methylcholanthrene than in that extracted from sarcoma induced by the same chemical.
19
New antibiotics, bleomycin A and B.
Hitoshi Umezawa, Kazuhiko Maeda, Tsutomu Takeuchi et al. · PubMed · 1966 · 732 citations
Hitoshi Umezawa, Yasuji Suhara, Toshichika Takita et al. · PubMed · 1966 · 177 citations
ON THE MECHANISM OF ACTION OF BLEOMYCIN
Hideo Suzuki, Kazuo Nagai, EMIKO AKUTSU et al. · The Journal of Antibiotics · 1970 · 139 citations · Full text